Equity

IHE

iShares U.S. Pharmaceuticals ETF

Add to Compare
  • NAV as of Feb 20, 2026 $89.80
    52 WK: 60.94 - 90.46
  • 1 Day NAV Change as of Feb 20, 2026 $-0.66 (-0.72%)
  • NAV Total Return as of Feb 19, 2026 YTD: 6.71%
  • Morningstar Rating
  • Fees as stated in the prospectus Expense Ratio: 0.38%

Overview

Why IHE?

1. Exposure to U.S. companies that manufacture prescription or over-the-counter drugs or vaccines

 

2. Targeted access to domestic pharmaceutical stocks

 

3. Use to express a sector view

INVESTMENT OBJECTIVE

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
Loading